Skip to content

â??Add on effect of Dhatri Nisha Yoga in Prameha (Diabetes Mellitus Type II).â??

â??Open labeled, controlled, randomized evaluation of adjuvant effect of triturated Dhatri Nisha Yoga in management of Prameha vis a vis Diabetes Mellitus (Type II).â??

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/04/008420
Enrollment
60
Registered
2017-04-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- known cases of Prameha or Diabetes Mellitus type 2 on OHA or Insulin therapy

Interventions

Intervention1: Dhatri Nisha Yoga: Dhatri Nisha Yoga contains Dhatri(Emblica Officinalis Gaertn),Nisha(Curcuma Longa Linn),which is acombination of ayurvedic herbs mentioned in classical text of Ayurve

Sponsors

College of Ayurved and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cases of both genders will be included. A known diabetic (Diabetes Mellitus type II) on OHA or Insulin therapy treatment. Patients presenting classical symptoms of Prameha. Patient with fasting blood sugar more than 150 mg% and post prandial blood sugar more than 200 mg%. Patient showing mild to poor control in HbA1c test Patients having chronic complications like Nephropathy, Neuropathy and Retinopathy

Exclusion criteria

Exclusion criteria: Patients with fasting blood sugar less than 150 mg% and post prandial blood sugar less than 200mg%. Pregnant and lactating mothers. Patients having acute complications like Hyperglycemic coma, Ketoacidosis, and infections like gangrene. Insulin Dependent Diabetes Mellitus (IDDM) and those patients who are under insulin therapy Patients suffering from other diseases such as Tuberculosis, Cardiac diseases, HIV.

Design outcomes

Primary

MeasureTime frame
Assessment of symptoms and effects on BSL fasting and post prandial, Urine sugar and glycosylated hemoglobin HbA1cTimepoint: 90 days (3 months)

Secondary

MeasureTime frame
Assessment of Lipid Profile, BOdy weight and body mass indexTimepoint: 90 days(3 months)

Countries

India

Contacts

Public ContactDr Lalit Vijay Patil

College of Ayurved and Research Centre

dr.shaileshd@gmail.com9763104451

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026